Home  »  Stock   »  Roll up the Sleeves! When the bell rang at previou...

Roll up the Sleeves! When the bell rang at previous close Albireo Pharma Inc. (ALBO) was up 11.00%

Albireo Pharma Inc. (ALBO) is priced at $19.27 after the most recent trading session. At the very opening of the session, the stock price was $18.35 and reached a high price of $20.2396, prior to closing the session it reached the value of $17.36. The stock touched a low price of $18.25.Recently in News on September 22, 2022, Albireo Announces $115 Million Royalty Monetization Agreement with Sagard. Upfront payment for continued clinical development and commercialization of Bylvay®. You can read further details here

Albireo Pharma Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $37.63 on 04/13/22, with the lowest value was $16.02 for the same time period, recorded on 09/07/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Albireo Pharma Inc. (ALBO) full year performance was -39.33%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Albireo Pharma Inc. shares are logging -48.79% during the 52-week period from high price, and 20.29% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $16.02 and $37.63.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1961245 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Albireo Pharma Inc. (ALBO) recorded performance in the market was -17.26%, having the revenues showcasing -3.17% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 396.38M, as it employees total of 130 workers.

The Analysts eye on Albireo Pharma Inc. (ALBO)

During the last month, 0 analysts gave the Albireo Pharma Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 21.65, with a change in the price was noted -12.55. In a similar fashion, Albireo Pharma Inc. posted a movement of -39.44% for the period of last 100 days, recording 374,845 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ALBO is recording 0.09 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical rundown of Albireo Pharma Inc. (ALBO)

Raw Stochastic average of Albireo Pharma Inc. in the period of last 50 days is set at 29.71%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 77.02%. In the last 20 days, the company’s Stochastic %K was 54.74% and its Stochastic %D was recorded 45.20%.

Considering, the past performance of Albireo Pharma Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -17.26%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -37.01%, alongside a downfall of -39.33% for the period of the last 12 months. The shares increased approximately by 5.42% in the 7-day charts and went up by 2.23% in the period of the last 30 days. Common stock shares were lifted by -3.17% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts